A pharmaceutical factory at Grangemouth is to expand, following a £45m investment.
Piramal Pharma Solutions has announced plans to build a new factory in the town.
It would take the total number of workers there to more than 250.
The company's hoping to make antibody drugs for other medicine developers.
Scottish Enterprise has invested £2.4 million into the expansion.
Scottish Enterprise chief executive Adrian Gillespie said: "Piramal's investment is tremendous news for Scotland's life sciences sector, one of the largest life sciences clusters in Europe, and is creating new, high-quality jobs that are crucial to our economic recovery.
"With Scottish Enterprise support, the company's Grangemouth site expansion proposals will deliver more R&D and production capacity for the development, scale-up and commercial manufacture of drugs in the global fight against cancer."
Piramal Pharma chief executive Peter DeYoung said: "This new development will more than double our ADC production capacity, strengthening our ability to service customers throughout the entire drug lifecycle."
Consultation on Stirling budget cuts
NHS Forth Valley expecting "high" demand
Falkirk man jailed for terrorism offences
Work complete after dip on Stirling slip road
Plans for Stirling visitor levy